1 |
Sabzghabaee AM, Eizadi-Mood N, Montazeri K, Yaraghi A, Golabi M. Fatality in paraquat poisoning. Singapore Med J. 2010; 51(6):496-500.
|
2 |
Zhang Y, Yu B, Wang N, Li T. Acute poisoning in Shenyang, China: a retrospective and descriptive study from 2012 to 2016. BMJ Open. 2018; 8(8):e021881.
doi: 10.1136/bmjopen-2018-021881
|
3 |
WHO. Suicide. Available at https://www.who.int/news-room/fact-sheets/detail/suicide.
|
4 |
Jiang YF, Kang J, Huang PP, Yao JX, Wang ZH, Jiang L, et al. Evaluation of gastric lavage efficiency and utility using a rapid quantitative method in a swine paraquat poisoning model. World J Emerg Med. 2020; 11(3):174-81.
doi: 10.5847/wjem.j.1920-8642.2020.03.008
|
5 |
Wang Y, Chen Y, Mao L, Zhao GJ, Hong GL, Li MF, et al. Effects of hemoperfusion and continuous renal replacement therapy on patient survival following paraquat poisoning. PLoS One. 2017; 12(7):e0181207.
doi: 10.1371/journal.pone.0181207
|
6 |
Xu YG, Lu YQ. Systematic review and meta-analysis of the efficacy and safety of immunosuppressive pulse therapy in the treatment of paraquat poisoning. J Zhejiang Univ Sci B. 2019; 20(7):588-97.
doi: 10.1631/jzus.B1800640
|
7 |
Hagiwara S, Iwasaka H, Matsumoto S, Noguchi T. An antisense oligonucleotide to HSP47 inhibits paraquatinduced pulmonary fibrosis in rats. Toxicology. 2007; 236(3):199207.
|
8 |
Dinis-Oliveira RJ, Duarte JA, Sánchez-Navarro A, Remião F, Bastos ML, Carvalho F. Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment. Crit Rev Toxicol. 2008; 38(1):13-71.
pmid: 18161502
|
9 |
Zeisberg EM, Kalluri R. Origins of cardiac fibroblasts. Circ Res. 2010; 107(12):1304-12.
doi: 10.1161/CIRCRESAHA.110.231910
|
10 |
Iwano M. EMT and TGF-beta in renal fibrosis. Front Biosci (Schol Ed). 2010; 2:229-38.
|
11 |
Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119(6):1420-28.
doi: 10.1172/JCI39104
|
12 |
Fabro AT, Minatel IO, Rangel MP, Halbwedl I, Parra ER, Capelozzi VL, et al. Usual interstitial pneumonia and smoking-related interstitial fibrosis display epithelial to mesenchymal transition in fibroblastic foci. Respir Med. 2014; 108(9):1377-86.
doi: 10.1016/j.rmed.2014.06.008
|
13 |
Tanjore H, Xu XC, Polosukhin VV, Degryse AL, Li B, Han W, et al. Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med. 2009; 180(7):657-65.
doi: 10.1164/rccm.200903-0322OC
|
14 |
Xie H, Tan JT, Wang RL, Meng XX, Tang X, Gao S. Expression and significance of HIF-1α in pulmonary fibrosis induced by paraquat. Exp Biol Med (Maywood). 2013; 238(9):1062-68.
doi: 10.1177/1535370213498978
|
15 |
Yamada A, Aki T, Unuma K, Funakoshi T, Uemura K. Paraquat induces epithelial-mesenchymal transition-like cellular response resulting in fibrogenesis and the prevention of apoptosis in human pulmonary epithelial cells. PLoS One. 2015; 10(3):e0120192.
doi: 10.1371/journal.pone.0120192
|
16 |
Tian R, Zhu Y, Yao J, Meng X, Wang J, Xie H, et al. NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis. Exp Cell Res. 2017; 357(2):328-34.
doi: 10.1016/j.yexcr.2017.05.028
|
17 |
Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014; 15(3):178-96.
doi: 10.1038/nrm3758
|
18 |
Li T, Yang X, Xin S, Cao Y, Wang N. Paraquat poisoning induced pulmonary epithelial mesenchymal transition through Notch1 pathway. Sci Rep. 2017; 7(1):924.
doi: 10.1038/s41598-017-01069-9
|
19 |
Huang M, Wang YP, Zhu LQ, Cai Q, Li HH, Yang HF. MAPK pathway mediates epithelial-mesenchymal transition induced by paraquat in alveolar epithelial cells. Environ Toxicol. 2016; 31(11):1407-14.
doi: 10.1002/tox.v31.11
|
20 |
Zhu Y, Wang J, Meng X, Xie H, Tan J, Guo X, et al. A positive feedback loop promotes HIF-1α stability through miR-210-mediated suppression of RUNX3 in paraquat-induced EMT. J Cell Mol Med. 2017; 21(12):3529-39.
doi: 10.1111/jcmm.2017.21.issue-12
|
21 |
Lu J, Qian Y, Jin W, Tian R, Zhu Y, Wang J, et al. Hypoxia-inducible factor-1α regulates epithelial-to-mesenchymal transition in paraquat-induced pulmonary fibrosis by activating lysyl oxidase. Exp Ther Med. 2018; 15(3):2287-94.
|
22 |
Xu Y, Tai W, Qu X, Wu W, Li Z, Deng S, et al. Rapamycin protects against paraquat-induced pulmonary fibrosis: activation of Nrf2 signaling pathway. Biochem Biophys Res Commun. 2017; 490(2):535-40.
doi: 10.1016/j.bbrc.2017.06.074
|
23 |
Zhu Y, Tan J, Xie H, Wang J, Meng X, Wang R. HIF-1α regulates EMT via the snail and β-catenin pathways in paraquat poisoning-induced early pulmonary fibrosis. J Cell Mol Med. 2016; 20(4):688-97.
doi: 10.1111/jcmm.2016.20.issue-4
|
24 |
Zhi QM, Sun HC, Qian XM, Nie SN, Xu BH, Tang WJ, et al. Experimental study on lung injury model induced by paraquat poisoning in rats. J Med Postgradu. 2008; 21(2):134-36.
|
25 |
Xu L, Xu J, Wang Z. Molecular mechanisms of paraquat-induced acute lung injury: a current review. Drug Chem Toxicol. 2014; 37(2):130-4.
doi: 10.3109/01480545.2013.834361
|
26 |
Wang J, Zhu Y, Tan J, Meng X, Xie H, Wang R. Lysyl oxidase promotes epithelial-to-mesenchymal transition during paraquat-induced pulmonary fibrosis. Mol Biosyst. 2016; 12(2):499-507.
doi: 10.1039/C5MB00698H
|
27 |
Han YY, Shen P, Chang WX. Involvement of epithelial-to-mesenchymal transition and associated transforming growth factor-β/Smad signaling in paraquat-induced pulmonary fibrosis. Mol Med Rep. 2015; 12(6):7979-84.
doi: 10.3892/mmr.2015.4454
|
28 |
Xie L, Zhou D, Xiong J, You J, Zeng Y, Peng L. Paraquat induce pulmonary epithelial-mesenchymal transition through transforming growth factor-β1-dependent mechanism. Exp Toxicol Pathol. 2016; 68(1):69-76.
doi: 10.1016/j.etp.2015.09.010
|
29 |
Xu GP, Li QQ, Cao XX, Chen Q, Zhao ZH, Diao ZQ, et al. The effect of TGF-β1 and Smad7 gene transfer on the phenotypic changes of rat alveolar epithelial cells. Cell Mol Biol Lett. 2007; 12(3):457-72.
|
30 |
Vongphouttha C, Zhu J, Deng S, Tai W, Wu W, Li Z, et al. Rapamycin protects against paraquat-induced pulmonary epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway. Exp Ther Med. 2018; 15(3):3045-51.
doi: 10.3892/etm.2018.5795
pmid: 29599839
|